Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2024 | EDGE: increasing hereditary cancer screening rates in primary care

Elizabeth Swisher, MD, University of Washington, Seattle, WA, discusses findings from the EDGE trial (NCT04746794), which compared two engagement strategies for identifying primary care patients with cancer history, offering genetic testing for susceptibility. Rural and urban clinics were randomly assigned to point of care screening (POC) or direct patient engagement (DPE). While POC yielded higher screening rates, DPE resulted in more test completions. Further analyses will explore factors influencing screening and testing uptake to refine population-based hereditary cancer screening practices. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.